Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Kappelhoff, Bregt S."'
Publikováno v:
In Journal of Chromatography B 2003 792(2):353-362
Autor:
Kappelhoff Bregt S, Finnern Henrik W, Stegmeijer Simon, Veltman-Starkenburg Christa A, Bos Jasper M, Hubben Gijs AA, Simpson Kit N, Tramarin Andrea, Postma Maarten J
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 5, Iss 1, p 15 (2007)
Abstract Background This study compares the costs and effects of a regimen with ritonavir-boosted tipranavir (TPV/r) to a physician-selected genotypically-defined standard-of-care comparator protease inhibitor regimen boosted with ritonavir (CPI/r) i
Externí odkaz:
https://doaj.org/article/5ca6130d496147bbbad59ef7bda2f675
Publikováno v:
Drugs in R&D. 2005, Vol. 6 Issue 2, p61-69. 9p.
Publikováno v:
Journal of Medical Economics, 16(3), 372-373. Taylor & Francis Ltd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::e18e3f476ea8ce6f5d4af4e755c991d8
https://research.rug.nl/en/publications/d2b9ba58-1bd2-4d4d-8489-4b303ee4f5a4
https://research.rug.nl/en/publications/d2b9ba58-1bd2-4d4d-8489-4b303ee4f5a4
Autor:
Kappelhoff, Bregt S., van Leth, Frank, Robinson, Patrick A., MacGregor, Thomas R., Baraldi, Ezio, Montella, Francesco, Uip, David E., Thompson, Melanie A., Russell, Darren B., Lange, Joep M. A., Beijnen, Jos H., Huitema, Alwin D. R.
Publikováno v:
Antiviral therapy, 10(4), 489-498. International Medical Press Ltd
Objective: The relationships between adverse events (AEs) and plasma concentrations of nevirapine (NVP) and efavirenz (EFV) were investigated as part of the large, international, randomized 2NN study. Methods: Treatment-naive, HIV-1-infected patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::e04cbaa94589ee27141b78b49bdce0a6
https://pure.amc.nl/en/publications/are-adverse-events-of-nevirapine-and-efavirenz-related-to-plasma-concentrations(583660f2-67fd-4791-9ba9-8b3bf9262bd9).html
https://pure.amc.nl/en/publications/are-adverse-events-of-nevirapine-and-efavirenz-related-to-plasma-concentrations(583660f2-67fd-4791-9ba9-8b3bf9262bd9).html
Autor:
Kappelhoff, Bregt S., van Leth, Frank, MacGregor, Thomas R., Lange, Joep, Beijnen, Jos H., Huitema, Alwin D. R.
Publikováno v:
Antiviral therapy, 10(1), 145-155. International Medical Press Ltd
The aim of this 2NN pharmacokinetic substudy was to investigate the population pharmacokinetics of nevirapine and efavirenz. Treatment-naive, HIV-1-infected patients received nevirapine (once or twice daily), efavirenz or a combination with lamivudin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::1b49167e00d0b8164df0bf41df2bb7dd
https://pure.amc.nl/en/publications/nevirapine-and-efavirenz-pharmacokinetics-and-covariate-analysis-in-the-2nn-study(0203910d-9bfd-474b-9dba-77da5ebdab8d).html
https://pure.amc.nl/en/publications/nevirapine-and-efavirenz-pharmacokinetics-and-covariate-analysis-in-the-2nn-study(0203910d-9bfd-474b-9dba-77da5ebdab8d).html
Autor:
Hubben, Gijs A. A., Bos, Jasper M., Veltman-Starkenburg, Christa A., Stegmeijer, Simon, Finnern, Henrik W., Kappelhoff, Bregt S., Simpson, Kit N., Tramarin, Andrea, Postma, Maarten J.
Publikováno v:
Cost Effectiveness & Resource Allocation; 2007, Vol. 5, p15-23, 9p
Autor:
Kappelhoff, Bregt S., Huitema, Alwin D. R., Sankatsing, Sanjay U. C., Meenhorst, Pieter L., van Gorp, Eric C. M., Mulder, Jan W., Prins, Jan M., Beijnen, Jos H.
Publikováno v:
British Journal of Clinical Pharmacology; Sep2005, Vol. 60 Issue 3, p276-286, 11p
Autor:
Kappelhoff, Bregt S., Huitema, Alwin D.R., Yalvaç, Zeynep, Prins, Jan M., Mulder, Jan W., Meenhorst, Pieter L., Beijnen, Jos H., Yalvaç, Zeynep
Publikováno v:
Clinical Pharmacokinetics; 2005, Vol. 44 Issue 8, p849-861, 13p
Autor:
Kappelhoff, Bregt S., Huitema, Alwin D. R., Crommentuyn, Kristel M. L., Mulder, Jan W., Meenhorst, Pieter L., van Gorp, Eric C. M., Mairuhu, Albert T. A., Beijnen, Jos H.
Publikováno v:
British Journal of Clinical Pharmacology; Feb2005, Vol. 59 Issue 2, p174-182, 9p